GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » Cash, Cash Equivalents, Marketable Securities

Merck KGaA (WBO:MRCK) Cash, Cash Equivalents, Marketable Securities : €2,009 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Merck KGaA Cash, Cash Equivalents, Marketable Securities?

Merck KGaA's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 (€1,927.00 Mil) to Sep. 2023 (€2,583.00 Mil) but then stayed the same from Sep. 2023 (€2,583.00 Mil) to Dec. 2023 (€2,009.00 Mil).

Merck KGaA's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (€1,623.00 Mil) to Dec. 2022 (€1,642.00 Mil) and increased from Dec. 2022 (€1,642.00 Mil) to Dec. 2023 (€2,009.00 Mil).


Merck KGaA Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Merck KGaA's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Cash, Cash Equivalents, Marketable Securities Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 590.00 1,139.00 1,623.00 1,642.00 2,009.00

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,642.00 3,237.00 1,927.00 2,583.00 2,009.00

Merck KGaA Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Merck KGaA  (WBO:MRCK) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Merck KGaA Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (WBO:MRCK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » Cash, Cash Equivalents, Marketable Securities
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (WBO:MRCK) Headlines

No Headlines